Immage Biotherapeutics
OverviewSuggest Edit
Immage Biotherapeutics Corp. is a biotechnology company, develops novel immunotherapy biologics to treat various cancers in the United States. It focuses on the development, marketing, and licensing of its patented immunotherapy candidate IMT-001, a hybrid/fusion protein vaccine that targets various tumors that express melanoma-associated antigen-A gene, including breast, liver, pancreas, prostate, melanoma, and lung diseases.
| Type | Public | |
| Founded | 2015 | |
| HQ | Bethesda, MD, US | Map |
| Website | immagebio.com |
Immage Biotherapeutics Office Locations
Immage Biotherapeutics has an office in Bethesda
Bethesda, MD, US (HQ)
10411 Motor City Dr #750
Immage Biotherapeutics Financials and Metrics
Immage Biotherapeutics Revenue
| USD | |
|---|---|
Net income (Q2, 2017) | (44.1k) |
Market capitalization (12-Apr-2021) | 15.2k |
Closing stock price (12-Apr-2021) | 0.0 |
Cash (28-Feb-2017) | 53.7k |
EV | (38.4k) |
Immage Biotherapeutics's current market capitalization is $15.2 k.
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General and administrative expense | 1.1k | 2.2k | 839.0 | 685.0 | 2.0k | 1.5k | 4.3k | 19.8k | 27.3k | 26.0k | 28.0k | 24.4k |
R&D expense | 34.7k | 9.7k | 1.6m | 5.7k | ||||||||
Operating expense total | 1.1k | 2.2k | 839.0 | 685.0 | 2.0k | 1.5k | 4.3k | 19.8k | 62.0k | 35.7k | 1.7m | 30.1k |
EBIT | (4.1k) | (9.7k) | (4.5k) |
Annual
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (9.0k) | (10.6k) | (13.3k) | (17.4k) | (9.7k) | (14.2k) | (36.7k) | (34.0k) | (103.6k) | (154.5k) | (1.7m) | (1.7m) |
Depreciation and Amortization | 2.3k | 4.6k | 6.9k | 2.1k | 4.3k | |||||||
Accounts Payable | 860.0 | 1.8k | 1.8k | 2.0k | 7.4k | 11.9k | 7.1k | 4.4k | 13.3k | (413.0) | 45.1k | 12.7k |
Cash From Operating Activities | (8.2k) | (8.8k) | (11.5k) | (15.4k) | (2.3k) | (2.3k) | (29.5k) | (25.6k) | (84.8k) | (147.0k) | (71.1k) | (143.0k) |
| USD | Q3, 2013 |
|---|---|
Financial Leverage | -1 x |
Immage Biotherapeutics Cybersecurity Score
Immage Biotherapeutics Online and Social Media Presence
Immage Biotherapeutics's Trends
Immage Biotherapeutics Blogs
September 08, 2018
Acme Dining Room Sets
September 08, 2018
Dining Room Tables Sizes
September 08, 2018
Centerpieces For Dining Room Tables
September 08, 2018
Tables For Dining Room
September 08, 2018
Lowes Lighting Dining Room
September 08, 2018
White Washed Dining Room Table
Immage Biotherapeutics Frequently Asked Questions
When was Immage Biotherapeutics founded?
Immage Biotherapeutics was founded in 2015.
How many employees does Immage Biotherapeutics have?
Immage Biotherapeutics has 3 employees.
Who are Immage Biotherapeutics competitors?
Competitors of Immage Biotherapeutics include Themis Bioscience, Novadip Biosciences and Yumanity Therapeutics.
Where is Immage Biotherapeutics headquarters?
Immage Biotherapeutics headquarters is located at 10411 Motor City Dr #750, Bethesda.
Where are Immage Biotherapeutics offices?
Immage Biotherapeutics has an office in Bethesda.
How many offices does Immage Biotherapeutics have?
Immage Biotherapeutics has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies